<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Gabon</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Gabon.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/ga.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Molecular evidence of co-circulation of different dengue virus serotypes associated with malaria co-infection among febrile children in Libreville, Gabon</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108497-993c2f2d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108497-993c2f2d/</guid>
    <pubDate>Fri, 01 May 2026 00:00:00 GMT</pubDate>
    <description>The authors highlight the need to strengthen differential diagnostic approaches and surveillance strategies for acute febrile illnesses in urban Gabon, given overlapping clinical presentations and co-endemicity of dengue and malaria.</description>
    <category>Dengue</category>
    <category>Malaria</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Artesunate–pyronaridine–atovaquone–proguanil and artesunate–fosmidomycin–clindamycin compared with standard artesunate–pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and Ghana</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2025-101245-4f0f82f3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2025-101245-4f0f82f3/</guid>
    <pubDate>Sun, 01 Mar 2026 00:00:00 GMT</pubDate>
    <description>The authors position APAP and AFC as candidate multidrug combinations intended to address emerging artemisinin-reduced susceptibility in sub-Saharan Africa, warranting further clinical development.</description>
    <category>Malaria</category>
    <category>Treatment</category>
    <category>Antimicrobial resistance</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Mapping of Ebola virus spillover: Suitability and seasonal variability at the landscape scale</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009683-9f4cd271/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009683-9f4cd271/</guid>
    <pubDate>Mon, 23 Aug 2021 00:00:00 GMT</pubDate>
    <description>The authors frame GIS-MCE suitability maps as an updatable tool to support surveillance and prevention of future Ebola outbreaks as new knowledge becomes available.</description>
    <category>Ebola</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
